1. Home
  2. Blog

  3. Hospital Acquired Infection Control Market

HAIs Control Market Marks Prominence with Rising Interventions to Eliminate

Published On : Feb 01, 2015

Caused by bacterial, viral, and fungal pathogens, hospital-acquired infections (HAIs) can be dangerous for patients and their companions such as friends or family. To avoid such risk of infection in people visiting hospitals, the HAIs control market has emerged to help reduce the chances of acquiring extra infections. The HAIs control market is witnessing rapid and significant growth due to a number of market drivers and key developments. 

Lack of Trained Hospital Staff Increases Chances of HAIs

Hospital-acquired infections or nosocomial infections can occur in both developed and resource-poor countries. Among hospitalized patients, hospital-acquired infections are some of the major causes of increased morbidity. The most frequent nosocomial infections within the global hospital-acquired control market are urinary tract infections, infections of surgical wounds, and lower respiratory tract infections.      

Many other risk factors may increase the likelihood of a person acquiring HAI. These factors include:

  • Operations and surgical procedures
  • Overuse of antibiotics leading to resistant bacteria
  • Length of stay in the hospital that increases the risk of multiple illnesses
  • High-risk areas within the hospital that are more likely to have infections
  • Lack of proper sanitation in hospitals
  • Lack of public awareness among healthcare workers and
  • Poor hospital infrastructure  

Globally, the prevalence of all the above factors has helped the growth in demand for the HAIs control market. Increasing risk of hospital-acquired infections in hospitals and development of the overall infection control market have formed new market opportunities for the global HAIs control market to grow and improve.

Due to lack of training, poor infection control practices in hospitals, increasing geriatric population and people suffering from malnutrition and the consequently decreased levels of immunity, the need for more technical advancements and high focus on improved healthcare facilities has augmented in different regions of the world. 

Asia Pacific will Lead HAIs Control Market by 2020

Due to technical advancements, improved healthcare facilities, and increasing awareness to treat hospital-acquired infections, the U.S. represents the largest market for hospital-acquired infections control in the North American region. Expected to grow rapidly at a CAGR of 8.3% from 2014-2020, North America is considered to be the largest market within the global HAIs control market in 2013. The market for HAIs control in the North American region was valued at US$21,319.2 million in 2014 and is expected to reach US$34,430.3 million by the end of 2020. 

Factors such as rising prevalence of HAIs cases, increasing government initiatives expanding awareness about and promoting innovation in anti-HAI technology and procedures, growing demand for improved healthcare facilities, and increasing popularity of cleaning and gas plasma sterilization technology will increase in the Asia Pacific region. Therefore, Asia Pacific is expected to experience high growth rates in the hospital-acquired infections control market over the next five years.

HAI Control Market Outlook via Key Players and Market Statistics 

Some of the significant players in the HAIs control market include Hoffmann-La Roche, Ltd., Becton, Dickinson and Company, Advanced Sterilization Products Division Ethicon US, LLC, Cepheid, Pfizer, Inc, and Kimberly-Clark Corporation.  

STERIS Corporation, with a total share of about 25% in the cleaning and sterilization market, led the overall HAIs control market in 2013. Getinge AB is another company that accounts for around 24% in the same segment. 

According to a study report published by Persistence Market Research, the global HAIs control market was valued at US$50,807.0 million in 2014. However, the market is expected to grow at a CAGR of 8.5% from 2014 to 2020 in order to reach an estimated value of US$82,889.4 million by 2020.

Latest Reports

Research Methodology

Data-Driven Research Methodology for Accurate Insights

Read More